Canada markets close in 3 hours 48 minutes

Takara Bio Inc. (4974.T)

Tokyo - Tokyo Delayed Price. Currency in JPY
Add to watchlist
1,086.00-13.00 (-1.18%)
At close: 03:15PM JST
Currency in JPY

Valuation Measures4

Market Cap (intraday) 132.34B
Enterprise Value 81.46B
Trailing P/E 84.28
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.78
Price/Book (mrq)1.18
Enterprise Value/Revenue 1.71
Enterprise Value/EBITDA 12.54

Trading Information

Stock Price History

Beta (5Y Monthly) 0.21
52-Week Change 3-32.41%
S&P500 52-Week Change 326.36%
52 Week High 31,790.00
52 Week Low 3931.00
50-Day Moving Average 3995.66
200-Day Moving Average 31,209.66

Share Statistics

Avg Vol (3 month) 3336.94k
Avg Vol (10 day) 3276.95k
Shares Outstanding 5120.42M
Implied Shares Outstanding 6121.01M
Float 846.13M
% Held by Insiders 160.91%
% Held by Institutions 19.25%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 434
Forward Annual Dividend Yield 43.09%
Trailing Annual Dividend Rate 317.00
Trailing Annual Dividend Yield 31.55%
5 Year Average Dividend Yield 41.39
Payout Ratio 4322.09%
Dividend Date 3N/A
Ex-Dividend Date 4Mar 28, 2025
Last Split Factor 2400:1
Last Split Date 3Mar 29, 2011

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 3.40%
Operating Margin (ttm)6.36%

Management Effectiveness

Return on Assets (ttm)1.46%
Return on Equity (ttm)1.35%

Income Statement

Revenue (ttm)43.51B
Revenue Per Share (ttm)361.29
Quarterly Revenue Growth (yoy)-32.00%
Gross Profit (ttm)N/A
EBITDA 7.95B
Net Income Avi to Common (ttm)1.48B
Diluted EPS (ttm)13.08
Quarterly Earnings Growth (yoy)-86.00%

Balance Sheet

Total Cash (mrq)35.42B
Total Cash Per Share (mrq)294.11
Total Debt (mrq)968M
Total Debt/Equity (mrq)0.87%
Current Ratio (mrq)8.76
Book Value Per Share (mrq)925.99

Cash Flow Statement

Operating Cash Flow (ttm)1.71B
Levered Free Cash Flow (ttm)-14.89B